Company news
Conneqt Health Limited (ASX:CQT) news
Conneqt Health Limited news releases on 6ix. Latest, Sep 6, 2026: CQT Expands US Distribution Through Blueprint Agreement
Press releases & updates
CQT Expands US Distribution Through Blueprint Agreement
September 6, 2026
CQT Announces SPP Launch, Booklet & Timetable
June 29, 2026
CONNEQT Lodges FDA Pre-Submission for SphygmoCor Cloud
June 22, 2026
CONNEQT Completes $5.5m Placement
June 18, 2026
Half Yearly Report and Accounts
February 27, 2026
December Quarterly Appendix 4C
January 29, 2026
December Quarterly Activities Report
January 29, 2026
CONNEQT Completes $3.1m Institutional Placement
December 21, 2025
Trading Halt
December 18, 2025
Pause in Trading
December 18, 2025
CONNEQT Health December Quarter Sales Update
December 15, 2025
September Quarterly Activities Report
October 29, 2025
September Quarterly Appendix 4C
October 29, 2025
New US Clinical Trial Contract
October 27, 2025
CONNEQT Pulse Sales Update
October 20, 2025
Appendix 4E Update
October 2, 2025
Convertible Note Facility
October 1, 2025
FY25 Preliminary Results Summary and Company Update
August 29, 2025
Appendix 4E
August 29, 2025
June Quarterly Appendix 4C
July 31, 2025
June Quarterly Activities Report
July 31, 2025
Results of Entitlement Offer
June 24, 2025
Offer Booklet - Non-Renounceable Entitlement Offer
June 5, 2025
Cardiex Receives TGA Approval for CONNEQT Pulse Device
June 2, 2025
CDX May Investor Presentation
May 30, 2025
Cardiex Completes Placement & Launches Entitlement Offer
May 30, 2025
Lodgement of CONNEQT Pulse Device with the TGA
May 5, 2025
March Quarterly Activities Report
April 30, 2025
March Quarterly Appendix 4C
April 30, 2025
CONNEQT Launches Apple Health Integration on iPhone
March 31, 2025
Launch of New Cardiology Report Feature in CONNEQT App
March 24, 2025
Response to ASX Price Query Letter
February 17, 2025
CONNEQT App Launches in USA as Pulse Deliveries Commence
January 23, 2025
Cardiex Completes Placement Ahead of CONNEQT US Launch
December 17, 2024
CONNEQT Pulse Pre-orders Commence
October 31, 2024
Cardiex Sales and Operations Update
June 18, 2024
Options Prospectus
June 17, 2024
Completion of Wearable Study and New Wearable Patent
April 1, 2024
Funding Commitment Agreement Update
March 14, 2024
ASX Relisting and Market Update
February 25, 2024
Reinstatement to Official Quotation
February 23, 2024
Reinstatement Disclosure - CDX Pro-forma Balance Sheet
February 23, 2024
Supplementary Prospectus for Entitlement Offer
January 17, 2024
ASX Conditional Approval to Lift Suspension
January 1, 2024
Revised Timetable for Prospectus
December 19, 2023
CDX December Investor Presentation
December 19, 2023
Prospectus for Entitlement Offer & Quoted Options
December 19, 2023
CardieX Completes Placement & Launches Entitlement Offer
December 19, 2023
Receipt of Clinichain Trial Funds
December 7, 2023
CardieX AGM Executive Update
November 29, 2023